Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial (Q42851077)
Jump to navigation
Jump to search
scientific article published on 19 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial |
scientific article published on 19 October 2010 |
Statements
1 reference
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial (English)
1 reference
François-Xavier Mahon
1 reference
Joëlle Guilhot
1 reference
Françoise Huguet
1 reference
Franck Nicolini
1 reference
Laurence Legros
1 reference
Aude Charbonnier
1 reference
Agnès Guerci
1 reference
Bruno Varet
1 reference
Gabriel Etienne
1 reference
Josy Reiffers
1 reference
Philippe Rousselot
1 reference
Intergroupe Français des Leucémies Myéloïdes Chroniques
1 reference
19 October 2010
1 reference
1 reference
Identifiers
1 reference